Managing Lung Cancer with Comorbid Interstitial Pneumonia

Systemic therapy for advanced non-small cell lung cancer (NSCLC) has dramatically changed in the latest 15 years. Molecular-targeted therapy has brought about an era of precision medicine, and immune checkpoint inhibitors have brought hope for a cure for advanced NSCLC. In the wake of this remarkabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichihara, Eiki, Miyahara, Nobuaki, Maeda, Yoshinobu, Kiura, Katsuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008037/
https://www.ncbi.nlm.nih.gov/pubmed/31534086
http://dx.doi.org/10.2169/internalmedicine.3481-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008037/
https://www.ncbi.nlm.nih.gov/pubmed/31534086
http://dx.doi.org/10.2169/internalmedicine.3481-19

Ejemplares similares